Biocon’s subsidiary Biocon Pharma has received the Food and Drug Administration’s permission for norepinephrine bitartrate injection (4 mg/4 ml, 1 mg/ml) in a single-dose vial, the company said in a ...

Global Norepinephrine Bitartrate Injection Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 recently released by MarketsandResearch.biz include historical and projected ...

Baxter International Inc. BAX recently announced the receipt of the FDA’s approval and commercial launch of premix (ready-to-use) Norepinephrine Bitartrate in 5% Dextrose Injection (norepinephrine).

Caplin Steriles Limited (Caplin), a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval from the United States Food and Drug Administration (USFDA) for its ...

A new option for manufactured Premix Norepinephrine Bitartrate in 0.9% Sodium Chloride will help meet supply reliability and patient safety needs ROSEMONT, Ill., May 4, 2023 /PRNewswire/ -- Long Grove ...

Rare Drug Side Effect Highlights Unique MS Feature PharMEDium Services, LLC announced a voluntary recall of 29 lots of 4mg Norepinephrine Bitartrate (16mcg/mL) added to 0.9% Sodium Chloride in 250mL ...

Norepinephrine is a catecholamine indicated for restoration of blood pressure in adult patients with acute hypotensive states. Baxter International has announced the commercial launch of premix ...

Five new launches reinforce Baxter’s focus on differentiated products and enhance the company’s Pharmaceuticals portfolio in critical therapeutic areas Products feature ready-to-use formulations to ...

First and only manufacturer-prepared premix formulation of norepinephrine available Offers variety of storage options under refrigeration and at room temperature, allowing drug to be placed closer to ...

Baxter International Inc. BAX recently announced the receipt of the FDA’s approval and commercial launch of premix (ready-to-use) Norepinephrine Bitartrate in 5% Dextrose Injection (norepinephrine).